Human CXCL10/IP-10 ELISA Kit - Quantikine Best Seller
R&D Systems, part of Bio-Techne | Catalog # DIP100
Key Product Details
Assay Length
Sample Type & Volume Required Per Well
Sensitivity
Assay Range
Product Summary for Human CXCL10/IP-10 Quantikine ELISA Kit
Product Specifications
Assay Type
Format
Measurement
Detection Method
Conjugate
Reactivity
Specificity
Cross-reactivity
Interference
Sample Values
| Sample Type | Mean (pg/mL) | Range (pg/mL) |
| Serum (n=60) | 89 | 38-361 |
| EDTA plasma (n=35) | 96 | 47-382 |
| Heparin plasma (n=35) | 110 | 52-450 |
| Saliva (n=5) | 729 | 292-1340 |
| Sample Type | Mean of Detectable (pg/mL) | % Detectable | Range (pg/mL) |
| Urine (n=18) | 17.2 | 67 | ND-49.7 |
| Condition | Day 1 (pg/mL) | Day 5 (pg/mL) |
| Unstimulated | 29,774 | 21,900 |
| Stimulated | 18,456 | 11,091 |
THP-1 human acute monocyte leukemia cells were cultured in RPMI supplemented with 10% fetal bovine serum, 50 μM beta-mercaptoethanol, 2 mM L-glutamine, 100 U/mL penicillin, and 100 μg/mL streptomycin sulfate. Cells were stimulated with 1.0 μg/mL recombinant human IFN-gamma for 8 hours and then 1.0 μg/mL LPS was added. Cells were incubated for an additional 18 hours. An aliquot of the cell culture supernate was removed, diluted 600-fold and assayed, and measured 164,640 pg/mL.
Precision
Intra-Assay Precision (Precision within an assay) Three samples of known concentration were tested on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays) Three samples of known concentration were tested in separate assays to assess inter-assay precision.
Cell Culture Supernates, Saliva, Urine
| Intra-Assay Precision | Inter-Assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 40 | 40 | 40 |
| Mean (pg/mL) | 70.3 | 174 | 342 | 80.7 | 194 | 362 |
| Standard Deviation | 2.07 | 5.15 | 10.74 | 7.91 | 13.48 | 24.27 |
| CV% | 2.9 | 3.0 | 3.1 | 9.8 | 6.9 | 6.7 |
EDTA Plasma, Heparin Plasma, Serum
| Intra-Assay Precision | Inter-Assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 40 | 40 | 40 |
| Mean (pg/mL) | 67.4 | 168 | 334 | 70.7 | 182 | 366 |
| Standard Deviation | 3.12 | 4.99 | 11.15 | 6.23 | 11.12 | 18.93 |
| CV% | 4.6 | 3.0 | 3.3 | 8.8 | 6.1 | 5.2 |
Recovery for Human CXCL10/IP-10 Quantikine ELISA Kit
The recovery of IP-10 spiked to levels throughout the range of the assay in various matrices was evaluated.
| Sample Type | Average % Recovery | Range % |
|---|---|---|
| Cell Culture Media (n=4) | 95 | 88-101 |
| EDTA Plasma (n=5) | 99 | 90-109 |
| Heparin Plasma (n=5) | 99 | 87-113 |
| Serum (n=5) | 99 | 88-112 |
Linearity
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of IP-10 were serially diluted with the appropriate Calibrator Diluent to produce samples with values within the dynamic range of the assay.
Scientific Data Images for Human CXCL10/IP-10 Quantikine ELISA Kit
Human CXCL10/IP-10/CRG-2 ELISA Calibrator Diluent RD5K Standard Curve
Human CXCL10/IP-10/CRG-2 ELISA Calibrator Diluent RD6Q Standard Curve
Preparation and Storage
Shipping
Stability & Storage
Background: CXCL10/IP-10/CRG-2
CXCL10/IP-10 is an ELR- angiostatic chemokine that interacts with CXCR3 to attract Th1 cells, eosinophils, monocytes, and NK cells to sites of inflammation. It is upregulated by activated T lymphocytes, neutrophils, splenocytes, keratinocytes, osteoblasts, astrocytes, endothelial cells, smooth muscle cells, and pancreatic beta cells. CXCL10 contributes to disease pathology in many chronic inflammatory disorders including rheumatoid arthritis, psoriasis, cancer, multiple sclerosis, diabetes, and cardiovascular disease.
Additional CXCL10/IP-10/CRG-2 Products
Product Documents for Human CXCL10/IP-10 Quantikine ELISA Kit
Product Specific Notices for Human CXCL10/IP-10 Quantikine ELISA Kit
For research use only
⚠ WARNING: This product can expose you to chemicals including N,N-Dimethylforamide, which is known to the State of California to cause cancer. For more information, go to www.P65Warnings.ca.gov.